GeneOne Life Science Inc (011000) — Working Capital to Net Assets Ratio
GeneOne Life Science Inc (011000) has a Working Capital to Net Assets ratio of -57.2% as of March 2026. Working capital of ₩-29.25 Billion (current assets of ₩24.67 Billion minus current liabilities of ₩53.92 Billion) is measured against net assets of ₩51.15 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See GeneOne Life Science Inc (011000) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
GeneOne Life Science Inc Working Capital to Net Assets (2013–2025)
This chart shows how GeneOne Life Science Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at -57.2%, reflecting working capital of ₩-29.25 Billion against net assets of ₩51.15 Billion KRW. For the complete balance sheet picture, see how large is GeneOne Life Science Inc's balance sheet.
Annual Working Capital to Net Assets for GeneOne Life Science Inc (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for GeneOne Life Science Inc from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check GeneOne Life Science Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -84.0% | ₩-34.37 Billion | ₩40.90 Billion | ₩19.44 Billion | ₩53.81 Billion | ▼ -67.8 pp |
| 2024 | -16.2% | ₩-13.87 Billion | ₩85.61 Billion | ₩28.64 Billion | ₩42.51 Billion | ▼ -26.7 pp |
| 2023 | 10.5% | ₩11.71 Billion | ₩111.49 Billion | ₩34.57 Billion | ₩22.87 Billion | ▼ -11.1 pp |
| 2022 | 21.6% | ₩39.23 Billion | ₩181.47 Billion | ₩73.06 Billion | ₩33.84 Billion | ▼ -27.0 pp |
| 2021 | 48.6% | ₩99.87 Billion | ₩205.45 Billion | ₩134.63 Billion | ₩34.76 Billion | ▼ -24.5 pp |
| 2020 | 73.1% | ₩72.06 Billion | ₩98.51 Billion | ₩108.76 Billion | ₩36.71 Billion | ▲ +15.2 pp |
| 2019 | 58.0% | ₩13.94 Billion | ₩24.06 Billion | ₩36.60 Billion | ₩22.65 Billion | ▼ -7.9 pp |
| 2018 | 65.9% | ₩19.37 Billion | ₩29.41 Billion | ₩38.18 Billion | ₩18.81 Billion | ▼ -5.5 pp |
| 2017 | 71.4% | ₩26.08 Billion | ₩36.54 Billion | ₩34.65 Billion | ₩8.57 Billion | ▲ +3.8 pp |
| 2016 | 67.6% | ₩24.23 Billion | ₩35.85 Billion | ₩52.91 Billion | ₩28.68 Billion | ▼ -4.9 pp |
| 2015 | 72.5% | ₩28.59 Billion | ₩39.44 Billion | ₩35.28 Billion | ₩6.69 Billion | ▲ +0.0 pp |
| 2014 | 72.5% | ₩25.16 Billion | ₩34.73 Billion | ₩29.44 Billion | ₩4.28 Billion | ▲ +17.2 pp |
| 2013 | 55.2% | ₩13.09 Billion | ₩23.71 Billion | ₩19.50 Billion | ₩6.41 Billion | — |